A robust and versatile mass spectrometry platform for comprehensive assessment of the thiol redox metabolome by Sutton, T. R. et al.
 
 
University of Birmingham
A robust and versatile mass spectrometry platform
for comprehensive assessment of the thiol redox
metabolome
Sutton, T. R.; Minnion, M.; Barbarino, F.; Koster, G.; fernandez, B. O.; Cumpstey, A. F.;
Wischmann, P.; Madhani, Melanie; Frenneaux, M. P.; Postle, A. D.; Cortese-Krott, M. M.;
Feelisch, M.
DOI:
10.1016/j.redox.2018.02.012
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Sutton, TR, Minnion, M, Barbarino, F, Koster, G, fernandez, BO, Cumpstey, AF, Wischmann, P, Madhani, M,
Frenneaux, MP, Postle, AD, Cortese-Krott, MM & Feelisch, M 2018, 'A robust and versatile mass spectrometry
platform for comprehensive assessment of the thiol redox metabolome', Redox Biology, vol. 16, pp. 359-380.
https://doi.org/10.1016/j.redox.2018.02.012
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Published in Redox Biology on 19/02/2018
DOI: 10.1016/j.redox.2018.02.012
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Contents lists available at ScienceDirect
Redox Biology
journal homepage: www.elsevier.com/locate/redox
A robust and versatile mass spectrometry platform for comprehensive
assessment of the thiol redox metabolome
T.R. Suttona,1, M. Minniona,1, F. Barbarinob, G. Kostera, B.O. Fernandeza, A.F. Cumpsteya,
P. Wischmannb, M. Madhanic, M.P. Frenneauxd, A.D. Postlea, M.M. Cortese-Krottb, M. Feelischa,⁎
a Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton; NIHR Southampton Biomedical Research Centre, University of Southampton and
University Hospital Southampton NHS Foundation Trust, Southampton, UK
b Cardiovascular Research Laboratory, Division of Cardiology, Pulmonology & Vascular Medicine, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
c Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK
dNorwich Medical School, University of East Anglia, Norwich, UK
A R T I C L E I N F O
Keywords:
Oxidative stress
Redox status
Reactive species interactome
Glutathione
Hydrogen sulﬁde
Persulﬁdes
Thiol-maleimide michael addition
A B S T R A C T
Several diseases are associated with perturbations in redox signaling and aberrant hydrogen sulﬁde metabolism,
and numerous analytical methods exist for the measurement of the sulfur-containing species aﬀected. However,
uncertainty remains about their concentrations and speciation in cells/bioﬂuids, perhaps in part due to diﬀer-
ences in sample processing and detection principles. Using ultrahigh-performance liquid chromatography in
combination with electrospray-ionization tandem mass spectrometry we here outline a speciﬁc and sensitive
platform for the simultaneous measurement of 12 analytes, including total and free thiols, their disulﬁdes and
sulﬁde in complex biological matrices such as blood, saliva and urine. Total assay run time is< 10min, enabling
high-throughput analysis. Enhanced sensitivity and avoidance of artifactual thiol oxidation is achieved by taking
advantage of the rapid reaction of sulfhydryl groups with N-ethylmaleimide. We optimized the analytical pro-
cedure for detection and separation conditions, linearity and precision including three stable isotope labelled
standards. Its versatility for future more comprehensive coverage of the thiol redox metabolome was demon-
strated by implementing additional analytes such as methanethiol, N-acetylcysteine, and coenzyme A. Apparent
plasma sulﬁde concentrations were found to vary substantially with sample pretreatment and nature of the
alkylating agent. In addition to protein binding in the form of mixed disulﬁdes (S-thiolation) a signiﬁcant
fraction of aminothiols and sulﬁde appears to be also non-covalently associated with proteins. Methodological
accuracy was tested by comparing the plasma redox status of 10 healthy human volunteers to a well-established
protocol optimized for reduced/oxidized glutathione. In a proof-of-principle study a deeper analysis of the thiol
redox metabolome including free reduced/oxidized as well as bound thiols and sulﬁde was performed.
Additional determination of acid-labile sulﬁde/thiols was demonstrated in human blood cells, urine and saliva.
Using this simpliﬁed mass spectrometry-based workﬂow the thiol redox metabolome can be determined in
samples from clinical and translational studies, providing a novel prognostic/diagnostic platform for patient
stratiﬁcation, drug monitoring, and identiﬁcation of new therapeutic approaches in redox diseases.
1. Introduction
Many biological processes that have previously been associated with
an overproduction of reactive oxygen species (ROS) and/or an impaired
antioxidant and free radical scavenging capacity were thought to cul-
minate in ‘oxidative stress’, cell death and tissue damage. More re-
cently, such conditions are interpreted to reﬂect situations in which a
shift in redox poise has occurred, aﬀecting both global and regional
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redox status and cysteine-based redox signaling [1–3]. Importantly,
unfavorable outcomes may not be inevitable if intervened early on.
Consequently, there is an increased interest in analytical methods that
provide a more reﬁned mapping of the associated metabolic changes
and enable further study of the underlying mechanisms.
In parallel with those developments, there has been a resurgence of
interest in the biological eﬀects of hydrogen sulﬁde (H2S)2 and related
oxidation products such as persulﬁdes and polysulﬁdes [4–6]. No spe-
ciﬁc biological targets have yet been identiﬁed for those compounds,
and many of their eﬀects appear to be mediated by interaction with
metals, heme proteins or redox interaction with other sulfur species.
Moreover, sulﬁde is involved in post-translational protein modiﬁcation
(persulﬁdation, S-sulfhydration) whereby reactive cysteine groups in-
volved in redox signaling are modiﬁed, resulting in altered chemical
reactivity and protein function [7].
Interestingly, ROS were shown to chemically and functionally in-
teract with nitric oxide (NO) and other reactive nitrogen species (RNS),
as well as with sulﬁde-related reactive sulfur species (RSS) such as thiyl
radicals, persulﬁdes and polysulﬁdes. Our group recently proposed that
the interaction of ROS, RNS and RSS with each other and with their
thiol targets constitute a ‘reactive species interactome’ (RSI) that reg-
ulates fundamental cellular processes involved in stress signaling [3].
The RSI enables single cells and whole organisms to sense and adapt to
alterations in nutritional, metabolic and environmental conditions [3].
A corollary of this concept is that assessment of only a few constituents
of this RSI as “markers of oxidative stress” (e.g. oxidized lipids) will not
be suﬃcient to provide useful insight as they cannot adequately capture
the complexity of the chemical interactions within the RSI. This may
explain why the redox community has been struggling in successfully
identifying the key regulatory nodes and operating principles of this
interaction network, and to e.g. understand how speciﬁc thiols and
redox switches like the nuclear factor erythroid 2 [NF-E2]-related factor
2 (Nrf2) contribute to redox homeostasis in health and disease. Thus,
the renewed interest in sulﬁde related phenomena, antioxidant pro-
cesses and redox signaling demands quantiﬁcation of pertinent redox-
regulated events in much higher resolution than hitherto accomplished.
Given that glutathione is the major intracellular low-molecular-
weight (LMW) aminothiol, much of the earlier ‘oxidative stress’ litera-
ture revolved around pathways of formation and degradation of this
ubiquitous and (according to Helmut Sies) “inevitable” antioxidant [8],
besides the measurement of protein, lipid and DNA oxidation products
as biomarkers of an increased oxidative burden. As a result, many dif-
ferent methods have been developed to quantify glutathione and re-
lated metabolites in blood and tissues [9–12], and the ratio of reduced
over oxidized glutathione (GSH/GSSG) has been used for decades as a
sensitive oxidative stress biomarker [11,13,14]. In many of these
methods the sulfhydryl (-SH) group of the aminothiol is derivatized
with an electrophile such as monobromobimane (mBB), iodoacetic acid
(IAA), iodoacetamide (IAM) or N-ethylmaleimide (NEM). This reaction
step serves two purposes: i) it prevents ambient air mediated oxidation
of the thiols to their corresponding disulﬁdes [10,15] and ii) it con-
veniently forms a ﬂuorescent product [16], often improving sensitivity
limits for detection.
More recently, the cysteine/cystine (Cys/CysSS) redox couple
emerged, along with GSH/GSSG, as a powerful predictor of cardio-
vascular mortality [17]. Circulating total homocysteine has been used
as an integrative biomarker of folate and methionine metabolism, co-
balamine deﬁciency and cardiometabolic risk for some time [18], while
the mixture of “free thiols” and “protein-bound thiols” (including glu-
tathione, cysteine, and homocysteine; please refer to Box 1 for deﬁni-
tions of terms in italics) was proposed to reﬂect the plasma redox thiol
status more than 2 decades ago [19,20]. Most of the methods used to
determine these species employ either high pressure liquid chromato-
graphy (HPLC) or a similar chromatographic separation technique
coupled to a ultraviolet, ﬂuorescence or electrochemical detector. In
more recent applications these detectors have been replaced by mass
spectrometers, potentially oﬀering more speciﬁc and sensitive mea-
surements [21,22].
There is accumulating evidence that these mesurements may be
applied in clinical settings to predict morbidity and mortality from
redox diseases [3]. Interestingly, even the rather simple spectro-
photometric measurement of total free thiol availability using a non-
selective free sulfhydryl probe (Ellman's reagent) in plasma or serum
has been demonstrated to have an astonishing power to predict graft
failure and mortality in renal transplant patients and cardiovascular
mortality in a heart failure cohort [23,24]. This suggests that the single
free SH group of circulating serum albumin may be another integrative
biomarker of redox-sensitive events in vivo [3]. S-cysteinylated and S-
glutathionylated albumin have also been proposed to represent useful
biomarkers of oxidative stress [25,26], and albumin itself may be an
important transporter of low-molecular weight thiols by allowing the
formation of reversible mixed disulﬁdes. The complexity of the me-
thionine recycling, transsulfuration and glutathione metabolic path-
ways suggests that no single biomarker will adequately capture overall
metabolic and redox status of all of these pathways at a global level.
Many diﬀerent assays for the quantiﬁcation of sulﬁde in seawater or
simple aqueous buﬀer systems exist, but not all are suited for the de-
tection of sulﬁde in biological material [27,28]. Modiﬁcations of a
century-old colorimetric technique, the methylene blue assay [29,30],
have been used by many research groups to detect sulﬁde in blood, and
reports from several groups hinted at associations between blood
pressure or metabolic status and methylene blue reactive material (in-
terpreted to reﬂect sulﬁde levels). While the overall speciﬁcity of the
methylene blue assay for sulfur and its low running costs continue to
contribute to its popularity, doubts have been raised as to its reliability
for the quantiﬁcation of sulﬁde in complex biological media [31]. In the
last couple of years a large number of ﬂuorimetric probes have been
developed to detect sulﬁde [32], but many retain some cross-reactivity
with other RSS. Moreover, an HPLC-based method with ﬂuorimetric
detection that employs the reaction of sulﬁde with mBB has been de-
veloped [33–35] and is now widely used for sulﬁde quantiﬁcation in
biological material. Most recently, the same reaction principle was
exploited to develop a more speciﬁc detection technique for sulﬁde
using liquid chromatography hyphenated to tandem mass spectrometry
[36].
In spite of all these developments, still relatively little is known
about speciﬁc pathways of sulﬁde metabolism (other than its oxidation
to thiosulfate and sulfate) in humans, and/or how changes in circu-
lating sulﬁde concentrations relate to plasma thiol redox status. Some of
the electrophilic compounds used to derivatise aminothiols before
chromatographic separation, such as mBB [16] and NEM [37,38], are
known to also react with sulﬁde. Surprisingly, this potential does not
yet seem to have been exploited in more recent approaches using mass
spectrometry to measure aminothiol concentrations together with sul-
ﬁde.
The aim of the present study was to describe the development of an
analytical platform that allows simultaneous determination of the thiol
redox metabolome, including total and free thiols, and their corre-
sponding disulﬁdes as well as sulﬁde in complex biological matrices
such as human blood, saliva and urine. We here present ﬁrst proof-of-
concept results of our own method development using NEM as alky-
lating agent for thiols and sulﬁde to achieve this objective, and discuss
advantages, pitfalls and limitations.
2 Hydrogen sulﬁde (H2S) in aqueous solution undergoes rapid ionization and is mainly
found in the form of HS- with negligible amounts of S2− at pH 7.4. For simplicity, the sum
of all three species is referred to as “sulﬁde” hereinafter.
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2. Materials and methods
2.1. Chemicals and reagents
Unless otherwise stated all reagents and materials were of the
highest purity available and purchased from Sigma-Aldrich
(Gillingham, UK or Munich, Germany). Dual stable isotope (13C, 15N)
labelled reduced (GSH) and oxidized glutathione (GSSG) were from
Cambridge Isotopes and obtained from CK Isotopes Ltd (Newtown
Unthank, UK), N-ethyl-d5-maleimide (d5-NEM) was from Sigma-
Aldrich. Sodium persulﬁde (Na2S2) was from Dojindo Europe (Neuss,
Germany). Hanks´ balanced salt solution +Ca2+ + Mg2+ (HBSS+)
was obtained from Invitrogen, bovine serum albumin (BSA) from Carl
Roth (Karlsruhe, Germany) and HPLC-grade solvents from either VWR
(Darmstadt, Germany) or Fisher Scientiﬁc (UK). Argon gas (> 99.99%)
was from BOC Group (Guildford, UK). Ultrapure N2 gas was produced
by a nitrogen generator (Parker Balston, UK).
2.2. Human participants
Blood was taken from healthy volunteers of either gender (20–58
years old) with informed consent to participate before enrollment.
Procedures were approved by the ethics committees of the Heinrich
Heine University of Dusseldorf (ClinicalTrials.gov Identiﬁer:
NCT02272530) and the University of Southhampton (ERGO 30507/
31426) and conducted in accordance with the Declaration of Helsinki.
2.3. Instrumentation and chromatography
The chromatography system used in most of the studies described
was a Waters Aquity ultrahigh performance liquid chromatography
(UPLC) system with a thermostatted autosampler (kept at 5 °C) and an
ultrahigh performance binary pump, coupled to a triple-quadrupole
mass spectrometer (Xevo TQ-S, Waters) equipped with a heated elec-
trospray ionization source (ESI).
Chromatographic separation of the target analytes was achieved
using a 1.6 µm Modus 100× 2.1mm Aqua UPLC column
(Chromatography Direct, Runcorn, UK) kept at a temperature of 30 °C;
mobile phase A was H2O with 0.15% formic acid and 5mM ammonium
formate and mobile phase B was 95% acetonitrile with 5% H2O, 0.15%
formic acid and 5mM ammonium formate. The chromatographic gra-
dient starts at 99% A, decreasing to 60% A over 4.5 min, before drop-
ping to 0% A over 0.5 min and being held at that level for 1.5 min. The
column is brought back up to 99% mobile phase A over 0.5min and
held at 99% for a further 1min to equilibrate. A ﬂow rate of 0.2 ml/min
was used throughout, and total run time including equilibration was
8min. An injection volume of 5 µl was used, with a wash step every ten
injections consisting of 100% mobile phase B for 5min, followed by a
blank using the regular gradient to control for potential carry-over and
column equilibration. We found that carry-over was negligible with two
needle rinse steps (300 µl methanol, followed by 600 µl H2O /acetoni-
trile 90/10%, v/v) between injections.
Our initial separation attempts used an Aquity UPLC CSH C18
(1.7 µm) 2.1× 100mm column (Waters) kept at 30 °C; mobile phase A
was H2O with 5mM ammonium formate and mobile phase B was 95%
acetonitrile with 5% H2O and 5mM ammonium formate. The chro-
matographic gradient started at 95% A, decreasing to 40% A over 5min
before returning to 95% A over 1min and being held at that level for a
further 1min, resulting in a total run time of 7min at a constant ﬂow
rate of 0.2 ml/min. Experimental results depicted in Fig. 3 and some
panels of Fig. 4 were obtained using these separation conditions, as
indicated in the ﬁgure legend.
Mass spectrometry settings were as follows: capillary voltage
2.80 kV, source oﬀset 6 V, desolvation gas ﬂow 800 L/h, cone gas ﬂow
150 L/h, nebulizer pressure 7.0 bar, collision gas (argon) ﬂow 0.14ml/
min, desolvation temperature 250 °C. All analytes were detected using
positive ionization in multiple reaction monitoring (MRM) mode with
speciﬁc precursor/product ion combinations identiﬁed and cone and
collision energies optimized for each individual compound during di-
rect infusion of authentic standards. For this, compounds were dis-
solved in NEM-containing buﬀer at a concentration of approx. 1 µM and
diluted in water containing 5mM ammonium formate. In positive
Box 1
The Thiol Redox Metabolome.
Thiol, compound carrying a sulfhydryl (–SH) group (often from a cysteine).
According to their molecular weight they are generally classiﬁed in (a) low molecular weight (LMW) thiols (e.g. cysteine, homocysteine,
glutathione) and (b) high molecular weight thiols, which include protein thiols.
According to their redox state they are classiﬁed as (a) reduced or “free” thiols (RSH), and (b) oxidized or “bound” thiols, where a thiol is
bound to another thiol via a disulﬁde bridge including (b1) symmetric disulﬁdes (RSSR), where a disulﬁde bond links two equal molecules e.g. 2
cysteines to yield cystine, 2 glutathione to give GSSG etc., or (c) mixed or asymmetric disulﬁdes (RS-SP), carrying a disulﬁde bond between two
diﬀerent LMW thiols or a LMW thiol and a protein.
According to the measurement protocol thiols are also classiﬁed in:
(a) Free thiols, the concentration of thiols that are assessed in a specimen by derivatization with a thiol reactive reagent, like NEM, mBB, or
IAM, for example. It may comprise (a1) LMW free thiols and (a2) (if proteins are not removed from the specimen before derivatization)
protein free thiols + LMW thiols (which as sum are deﬁned as total free thiols).
(b) Total thiols (or DTT-reactive thiols), the concentration of all thiols that can be determined if a specimen is treated with a strong reducing
agent such as DTT, which reduces disulﬁde bonds and liberates all oxidized bound thiols (RSSR, RSSP), and comprises free thiols (RSH)
+ oxidized / bound thiols (RSSR, RSSP).
(c) Acid-labile thiols, the concentration of LMW thiols that is liberated from binding to proteins or sulfane sulfur compounds following the
treatment of a biological sample with mineral acid (e.g. HCl); in the case of sulﬁde, this is known as “acid-labile sulfur” equivalents and
originates from the decomposition of inorganic and organic persulﬁdes and polysulﬁdes.
According to their concentrations, the thiols deﬁne:
(a) the redox status of a tissue/cell, according to the ratio of reduced/oxidized thiols
(b) the redox reserve (or total thiol status), which is an index of the total reducing capacity of a cell/tissue or organism that deﬁnes its resilience
to oxidative modiﬁcation.
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ionization mode the precursor (parent) compound is usually the pro-
tonated form of the starting material, and the fragmentation proﬁle is
dependent on the cone and collision energies applied; optimal detection
parameters for these were established separately for each compound
during direct infusion of authentic standards by varying those para-
meters and selecting the most suitable product (daughter) ion by in-
tensity and speciﬁcity. In order to maximise sensitivity, accuracy and
selectivity speciﬁc MRM time windows were used to minimize the
number of concurrent MRM transitions being monitored. For quantiﬁ-
cation purposes the MRM transitions were therefore only monitored
during the time window where the relevant compounds elute. For
speciﬁcs including the chemical structures of analytes and m/z values of
precursor> product couples monitored see Table 1. Signals were cap-
tured and data processed using MassLynx v.4.0 and Quanlynx v.4.0
software (Waters).
2.4. Quantiﬁcation
Quantiﬁcation of the compounds of interest was accomplished by
comparison of peak areas to external standards with variations in io-
nization eﬃciency (and potential loss during ultraﬁltration) adjusted
using stable isotope labelled internal standards. Each class of com-
pound, i.e. oxidized thiol, reduced thiol and sulﬁde-related species, has
a representative internal standard. For the oxidized thiols, 13C415N2-
Fig. 1. Development and optimization of the analytical procedure for detection of the thiol redox metabolome. (A) Metabolic pathways deﬁning the thiol
redox metabolome. (B) Reaction of NEM with sulﬁde and aminothiols (using cysteine as an example); the two positions where the sulfhydryl group can add to the
double bond (Michael addition reaction with sulfur adding either to C3 or C4 of the maleimide ring) leading to the formation of two distinct diastereomers are
indicated (with sulﬁde four diﬀerent diastereomers can be formed). (C) Chromatographic separation and selective detection by tandem mass spectrometry of
authentic stock solutions of all analytes using full registration for the entire run. (D) Chromatograms of stable isotope labelled internal standards. (E) Representative
chromatogram of the same analytes at their natural abundance in human plasma using speciﬁc time windows for selected groups of compounds. (F) Linearity of
detector response for main analytes (n=3).
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GSSG was used; for the reduced thiols 13C215N-GSH was derivatized
with an excess of NEM and used as internal standard. For sulﬁde, a
deuterated stable-isotope labelled standard (32S-(d5-NEM)2) was pre-
pared by reacting an exact amount of d5-NEM with a two-fold molar
excess of Na2S in ammonium phosphate buﬀer pH 7.4 for 30min at RT,
and removing excess sulﬁde by bubbling for 60min with high-purity
argon. A mixed internal standard working solution was prepared by
combining all three stable-isotope labelled compounds in ammonium
phosphate buﬀer pH 7.4. Speciﬁc MRM conditions were established to
monitor each of the internal standards (Table 1), and the ratio between
the signal intensity of each analyte and its corresponding internal
standard was used for quantiﬁcation. Stock solutions of standards
containing each analyte of interest were prepared fresh for each ana-
lysis in pH 7.4 ammonium phosphate buﬀer (except for cystine (CysSS)
and homocysteine (HCys), which were prepared in 0.1 N HCl, while
sulﬁde, persuﬁde and methanethiol were ﬁrst dissolved in water) and
serially diluted in buﬀer to construct a concentration response curve for
calibration; each concentration of standard was spiked with the same
ﬁnal concentration of stable isotope standards.
2.5. Derivatization of thiols and sulﬁde with NEM
Preliminary LC-MS/MS experiments carried out with mixed thiol
standards at room temperature (RT) and pH 7.4 revealed that the re-
action with NEM was complete for all analytes in under 10min. Those
results were conﬁrmed by spectrophotometric monitoring of NEM
consumption under the same conditions (302 nm; Cary 60 UV/vis
spectrophotometer), demonstrating rapid kinetics for the reactions of
NEM with GSH, cysteine (Cys) and Hcys (at a 1:1 molar ratio, reactions
were complete within 12–15 s) whereas the reaction between NEM with
sulﬁde (2:1 molar ratio) required 10min to run to completion. Optimal
pH was assessed by comparing reactions of NEM with either aqueous
standards of select thiols (GSH, Cys, HCys, sulﬁde and stable-isotope
labelled GSH) or by addition of NEM stocks prepared at diﬀerent pH to
human plasma. For those experiments, 100mM NEM stock solutions
were prepared in diﬀerent ammonium phosphate buﬀers adjusted to pH
6.0, 7.4, 8.0 and 9.0 and used within 5min of preparation. Freshly
prepared aqueous solutions of thiols were individually reacted with
NEM at these diﬀerent pH values at a ﬁnal concentration of 10mM
NEM, and after 5min waiting aliquots of these NEM-thiol incubates
were combined and analysed immediately. Endogenous thiols con-
tained in human plasma (obtained by centrifugation of EDTA blood
using the rapid centrifugation protocol as detailed in Section 2.8) were
derivatized using freshly prepared NEM stock solutions of diﬀerent pH
at a 1:10 v:v ratio (10mM NEM ﬁnal concentration).
2.6. Assay validation
Careful assay validation for linearity, over a range of biologically
relevant concentrations, and a preliminary assessment of precision,
reproducibility and limits of detection were carried out using authentic
standards, according to standard procedures, and are shown in Table 1
and Fig. 1. Full validation awaits further assay reﬁnement with inclu-
sion of additional analytes of interest.
2.7. Sample collection and storage
Venous blood was collected from healthy human volunteers using a
21-gauge (0.80mmx19mm) butterﬂy needle and BD Vacutainer™ tubes.
Following gentle mixing by inversion, blood was processed im-
mediately as described below. Saliva was collected using oral swabs
(Salivette™, Salimetrics, Carlsbad, CA, USA) followed by centrifugation;
a mid-stream urine sample was collected using a sterile urine container.
Sample aliquots were measured either fresh or transferred into cryo-
vials (Nunc), snap frozen in liquid nitrogen and stored at − 80 °C until
analysis.
2.8. Sample preparation procedure and optimization
For human plasma analysis, whole blood was collected directly into
EDTA BD vacutainer™ tubes and gently mixed by repeated inversion;
1 volume of NEM (100mM stock solution in PBS) was added to 9 vo-
lumes of blood within 1min, resulting in a ﬁnal conc of 10mM NEM
(1:10 dilution), again followed by gentle mixing. Stabilized, antic-
oagulated blood was then centrifuged for 1min at 3000 × g to separate
plasma from cellular components, snap frozen in liquid nitrogen and
kept at− 80 °C until analysis. Before analysis, NEM-derivatized plasma
samples were supplemented with the internal standard (dual stable-
isotope labelled GSSG and NEM-derivatized GSH as well as d5-NEM-
derivatized sulﬁde in ammonium phosphate buﬀer, 1:1 v/v; target
concentrations 100 nM GSH, 200 nM GSSG, 100 nM sulﬁde), and
afterwards samples were cleared by ultraﬁltration using spin columns
with a 10 kD cut-oﬀ (Millipore).
Each step of the sample preparation was carefully optimized and
validated. To compare detection of thiols and sulﬁde in plasma with
that in serum, whole blood was also collected into serum BD vacutai-
ners, incubated for 60min at RT to allow clotting, and then centrifuged
at 3000 × g according to the manufacturer's protocol. To test the eﬀects
of other anticoagulants, whole blood was collected into BD vacutainers
containing EDTA, heparin or citrate, diluted 9:1 with NEM (ﬁnal NEM
concentration 10mM), centrifuged at 800×g for 10min at 4 °C (see
Fig. 3). Centrifugation speed was optimized by comparing GSH levels in
plasma obtained by standard/low-speed centrifugation of whole blood
(800× g, 10min, 4 °C) with short/high-speed centrifugation (1min
3000×g or 3min 3000×g at 4 °C). Hemolysis was excluded by as-
sessing plasma free hemoglobin concentration by UV–visible spectro-
scopy [39]. Sample stability and stabilization conditions were de-
termined by focussing primarily on the levels of GSH, GSSG and sulﬁde
(although other thiols were assessed in parallel) when comparing the
addition of diﬀerent concentrations of NEM (1, 5, 10, 20mM ﬁnal
concentration) to whole blood, or when NEM addition was delayed by
speciﬁed periods of time (30 s; 5, 10, 15 and 20min). To test the eﬀects
of time of addition of NEM in whole blood, and also the eﬀects of
freeze/thawing on stabilized samples, the same blood sample was di-
vided into identical aliquots, which all underwent the indicated pro-
cedures (addition of NEM in whole blood or plasma, repeated freeze/
thawing, etc,).
2.9. Bound thiols, total thiols and acid-labile sulﬁde
To determine the concentration of total thiols, free thiols and bound-
thiols (see Box 1), NEM stabilized plasma was divided into two aliquots:
(a) to assess total thiols (= free thiols + bound thiols) one aliquot was
treated with 50mM dithiothreitol (DTT) for 30min, which reduces
LMW disulﬁdes and mixed disulﬁdes with proteins; (b) to determine
free thiols one aliquot was left untreated. In both aliquots thiol con-
centrations were assessed following NEM derivatization by LC-MS/MS
analysis, as indicated above. Bound thiols were calculated by subtracting
free thiols from total thiols. The same procedure was carried out with the
blood cell pellet (comprising red blood cells (RBCs), white blood cells,
and platelets), urine and saliva samples, except that incubation time
with DTT for urine and saliva was only 10min.
Optimal reaction conditions for the reduction of disulﬁdes by
treatment with DTT were established for each biological matrix. To this
end, samples were reacted with 10, 25, 50 and 100mM DTT for 10, 20,
30 and 60min at RT before addition of NEM; appropriate volumes of a
100mM NEM stock solution in ammonium phosphate buﬀer were then
added to neutralize all SH equivalents of DTT and yield an additional
10mM excess of NEM to ensure full capture of additionally released
thiols. An alternative incubation sequence was tested in which DTT was
added to NEM-treated human plasma to achieve (following neu-
tralization of the excess NEM) a similar ﬁnal DTT concentration. Results
obtained with either sequence were virtually identical.
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To test for the presence of acid-labile sulﬁde in blood cells, urine and
saliva, 50 µl of NEM-stabilized sample was placed in a septum-sealed
screw-cap vial and 200 µl 0.1 N HCl was added through the septum
using a gas-tight syringe. After 10min of incubation at RT the pH was
neutralized by addition of 20 µl 1 N NaOH, followed by vortexing and
addition of 20 µl 100mM NEM through the septum. Internal standards
were added after a further 10min of incubation, and samples were then
subjected to ultraﬁltration followed by LC-MS/MS analysis as described
above. It is important to note that acid treatment will liberate sulﬁde
from both LMW and protein-bound sulfane sulfur (and possibly other
sulfur species).
2.10. Alternative detection of free reduced/oxidized thiols by UPLC-QTOF
analysis (accuracy and method cross-validation)
25 µl of a solution consisting of 100mM NEM with 20mM EDTA in
PBS (ﬁnal [NEM] =10mM; ﬁnal [EDTA] = 2mM) were added to
225 µl of whole blood (9:1 (v/v) dilution). Blood cells and plasma were
separated via centrifugation of whole blood at 3000 g for 3min at 4 °C.
Plasma was collected, and proteins were precipitated by mixing plasma
1:1 (v/v) with 150 µl of an ice-cold solution containing 5% SSA and
10mM NEM in Mili-Q water. Additionally, 15 µl of the internal stan-
dard (either 2mM glutathione ethyl ester in Milli-Q water or the same
dual-labelled stable isotope GSH and GSSG standard mix as indicated
above) solution was added (1:10 relative to plasma volume). The
sample was mixed by vortexing, sonicated for 20 s and centrifuged at
10,000×g for 10min at 4 °C. The supernatant was collected and the
pellet extracted once more with the same volume of ice-cold 5% SSA
containing NEM (10mM) solution as before. After centrifugation at
10,000×g for 10min at 4 °C, supernatants were combined and mea-
sured with UPLC-quadrupole time of ﬂight (QToF) mass spectrometry
using an injection volume of 10 µl.
UPLC-QToF analysis was performed on an Agilent 1290 Inﬁnity
UPLC System with a binary pump and autosampler coupled to an
Agilent 6550 iFunnel QToF system. For analyte separation a Zorbax
Eclipse Plus C18 RRHD 2.1×50mm 1.8 µm column from Agilent was
used. Mobile phase A was 0.1% formic acid in Milli-Q water, and mo-
bile phase B was acetonitrile. Separation was accomplished using the
following conditions: 0–2min: 99% A; 2–7min: 99− 1% linear gra-
dient. An isocratic ﬂow at 1% A was then run for 5min (7–12min) to
wash the column. After 12min in total, the proportion of A was in-
creased again to 99% and kept constant for 4min. The method takes a
total of 16min at a ﬂow rate of 0.6 ml/min. Temperature was held
constant at 20 °C. Analytes were ionized in positive mode (ESI) using
the following conditions: gas temperature 220 °C, drying gas 12 L/min,
nebulizer: 35 psig, sheath gas temperature: 330 °C, sheath gas ﬂow:
11 L/min, capillary voltage: 2.5 kV, nozzle voltage: 1 kV and frag-
mentor voltage: 30 V. Analytes were determined using extracted ion
chromatograms of the total ion count.
2.11. Statistical analysis
Analyte levels were typically assessed in technical duplicates or
triplicates for at least two independent biological samples, as indicated
in ﬁgure legends. Data were analysed with GraphPad Prism 7.0c for
Mac. Outlier were identiﬁed by applying the ROUT method [40]. Data
were tested for normal distribution by using Shapiro-Wilk normality
testing. Data are reported as mean± SD (for technical replicates) or
SEM (for biological replicates), as indicated in the ﬁgure and table le-
gends. Group diﬀerences were tested either using 1-way or 2-way
ANOVA as required by the experimental setting, followed by an ap-
propriate multiple comparison post-hoc test (Dunnet's) or t-test (when
just two groups were being compared) as indicated in the ﬁgure legend.
Signiﬁcance was assumed when p < 0.05.
3. Results
3.1. Development of suitable detection and separation conditions
Method development started by selecting key compounds of interest
according to the scheme summarized in Fig. 1A, including HCys,
homocystine (HCysSS), Cys, CysSS, GSH, GSSG, cysteinylglycine (Cy-
sGly), glutamylcysteine (GluCys), and sulﬁde. This was followed by
establishing appropriate conditions for the detection of these analytes
by LC-MS/MS. To this end, authentic standards of reduced thiols were
reacted with excess NEM in buﬀered solution at pH 7.4 and mixed with
disulﬁde standards to ﬁnd suitable separation conditions by UPLC (see
reaction scheme for reduced thiols and sulﬁde with NEM depicted in
Fig. 1B). During the initial phase of development a standard C18 re-
versed phase column with a simple gradient elution proﬁle was used for
analyte separation, allowing us to make a number of general observa-
tions regarding their elution proﬁle.
We found that symmetric and mixed disulﬁdes (which do not react
with NEM as they lack a free thiol group) show limited retention on
reversed phase material, clustering together close to the solvent front;
this was followed by the group of maleimide-adducts of aminothiols,
with S-(NEM)2 eluting last. Thus, derivatizing reduced thiols with NEM
clearly prolongs their retention time on the column, particularly when
the derivatization product involves two succinimide groups, as with
sulﬁde. For some compounds more than others double peaks were ob-
served, a phenomenon previously described for Cys and GSH [41,42].
This has been attributed to the formation of two diasteromers that diﬀer
in position of the sulfur atom in relation to the maleimide nitrogen,
depending on where the reduced thiol adds to the double bond of the
pyrrole ring. Modifying elution conditions aﬀorded reasonably good
separation of NEM-containing adducts, but remained problematic for
disulﬁdes. We therefore opted for a multimodal resin in order to im-
prove retention of the highly polar analytes. The mixed mode Aqua
UHPLC column was found to oﬀer suitable properties, combining polar
separation characteristics with the stability and non-polar separation of
a traditional C18 column. This allowed for better separation of the more
polar thiols such as GSSG and HCysSS; however, CysSS was still not
retained well by the column and eluted with a poor peak shape close to
the solvent front. The order of elution of other derivatives remained
largely the same (Fig. 1C). Therefore, further optimization experiments
were carried out on the Aqua UHPLC column according to the separa-
tion procedure described in Section 2.3 of the Materials and Methods
section. Table 1 lists the structures of analytes of interest along with the
speciﬁc cone/collision energies used for their detection and typical
retention times observed using these separation conditions.
3.2. Internal standards
Since GSH is a major intracellular antioxidant and the GSH/GSSG
ratio in plasma and tissues widely regarded as the ‘gold standard’ for
the assessment of systemic or cellular redox status, we chose stable-
isotope labelled GSH and GSSG to account for variations in ionization
eﬃciency and possible loss of analyte during sample preparation.
Consistent with the known dynamics of glutathione in blood [9] on
spiking fresh or previously frozen plasma we observed a rapid loss of
internal standard, unless plasma was treated with NEM before addition.
Since this was observed with both reduced (fast) and oxidized (slower)
internal standard, we opted to alkylate the stable-isotope labelled GSH
standard and only added internal standards to the biological sample
pre-incubated with NEM for at least 10min. This measure eﬀectively
prevented any loss of internal standard even after sample deproteini-
zation (see Section 3.9 below). The disappearance of both reduced and
oxidized thiols was also observed on spiking blood plasma with Cys and
HCys.
Considering the unique chemistry of sulﬁde and its reaction with
two instead of one molecule(s) of NEM (Fig. 1B), we opted to include an
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additional stable-isotope labelled internal standard for this analyte.
Preliminary studies with 34S-(NEM)2 showed that the degree of ioni-
zation quenching of the sulﬁde adduct in a variety of biological ma-
trices indeed diﬀered from that of the dual-labelled GSH adduct on
occasion, justifying a separate internal standard for sulﬁde. However,
those earlier experiments also revealed that this particular compound
was not ideal as an internal standard; besides only diﬀering by two m/z
units (34S versus 32S) the natural abundance of the 34S isotope (4.2%)
means that high concentrations of endogenous sulﬁde can lead to in-
terference, necessitating the introduction of cumbersome mathematical
correction factors. This problem was overcome by the use of the pen-
tadeuterated NEM analogue, N-ethyl-d5-maleimide (d5-NEM) in pre-
paring the internal standard, which coelutes with the regular NEM
adduct of sulﬁde without showing any overlap due to the large diﬀer-
ence of 10m/z units.
Therefore, a deﬁned mixture of 13C415N2-GSSG, 13C215N-GS-NEM
and 32S-(d5-NEM)2 was prepared in ammonium phosphate buﬀer pH
7.4 and added to the mixture of internal standards of all analytes re-
acted with NEM, and compounds were detected using the speciﬁc MRM
conditions previously established by direct infusion of individual
compounds as listed in Table 1. The ratio between the signal intensity of
each analyte and its corresponding internal standard was used for
quantiﬁcation in the biological matrix (Fig. 1D).
3.3. Linearity, precision, limits of detection and reproducibility of the
method
A standard calibration set was prepared to determine linearity,
precision, limits of detection (LOD), applicability and reproducibility of
the method, whilst also allowing quantiﬁcation of the analytes in dif-
ferent biological matrices.
3.3.1. Linearity
Accurately weighed amounts of analytical-grade reduced thiols
were dissolved in the appropriate volume of NEM-supplemented am-
monium phosphate buﬀer and allowed to react for 5min at a 10-fold
molar excess of NEM over thiol. Accurately weighed sulﬁde was ﬁrst
dissolved in water before addition of a deﬁned volume of this con-
centrated stock to NEM-containing buﬀer in a septum-sealed reaction
vial under otherwise identical reaction conditions. NEM-derivatized
thiol and sulﬁde solutions were then combined with roughly equimolar
concentrations of the oxidized thiols to yield a stock solution of all
analytes to be tested. This mixed standard was serially diluted with
buﬀer to yield targeted ﬁnal concentrations of 10 μM, 5 μM, 1 μM,
500 nM, 100 nM, 50 nM, 10 nM and 5 nM when added to the biological
sample (2×more concentrated in the mixed standard). For most
compounds this is well within the physiological range, except for cel-
lular/tissue GSH levels (being in the low mM range), which may
therefore necessitate appropriate dilution of samples before analysis. To
each dilution of the standard calibration set and the biological samples
the same volume of internal standard was added yielding ﬁnal con-
centrations of 100 nM GSH, 200 nM GSSG, and 100 nM sulﬁde. This
allowed adjustment of peak areas by taking into account the ratios
between analyte and internal standard. All analytes showed excellent
linearity over a wide range of concentrations (> 3 orders of magni-
tude), with overall r2 values of between 0.994 and 0.999 (Fig. 1F).
3.3.2. Sensitivity and LOD
Using an injection volume of 5 µl achieved sensitivity limits were all in
the nanomolar range, diﬀering by class of compound and structure, with a
general order of disulﬁde> thiol adduct with one NEM>sulﬁde (two
NEM/thiol). Limits of detection and quantiﬁcation, deﬁned as signal-to-
noise ratio of> 3 and> 10, are listed in Table 1. Assay precision will be
determined at a later stage of method development.
3.3.3. Applicability and reproducibility
All analytes of interest could be readily detected in fresh human
plasma and quantiﬁed without problems in each sample measured.
Between-run reproducibility was tested for a pooled plasma sample
over several days and was better than 20% overall. Fig. 1 shows a ty-
pical chromatogram of standards (panel C) and a representative plasma
sample (panel E).
Our next eﬀorts focussed on exploring what eﬀects variations in
reaction conditions such as pH and sample preparation (blood collec-
tion, cell separation, and stabilization) may have on analyte con-
centrations detected.
3.4. Optimization of reaction conditions for thiol derivatization with NEM
Reaction conditions were optimized to perform well under biolo-
gically relevant conditions. At neutral pH, NEM rapidly reacts with
thiols [43], and this was experimentally conﬁrmed to extend to phy-
siological pH using a thiol standard mixture. Since the reaction was
found to be complete in under 10min no additional work was under-
taken to further optimize reaction temperature or time as this was
considered well within the timeframe required for the processing of
biological samples, their placement into the sample compartment of the
UPLC, and initiation of the ﬁrst chromatographic run.
Reaction pH is known to be critical for thiol alkylation by NEM for a
number of reasons (see Discussion for details), and pH values in the
range of 6.5–7.5 have been used in most previous studies. Human blood
plasma deviates very little from its normal physiological pH of 7.40
under most conditions and is naturally buﬀered to maintain its pH. We
therefore sought to experimentally test these assumptions by carrying
out a series of experiments with select analytes (GSH, Cys, HCys and
sulﬁde), varying the pH from 6 to 9 in an aqueous buﬀer system; those
experiment were complemented by additional incubations of NEM with
human plasma at the same pH values. The results of these studies are
displayed in Fig. 2.
The results reveal clear diﬀerences between the reaction of NEM
with structurally distinct thiols. Whereas little diﬀerence was found for
the calibration curves for sulﬁde between pH 6 and 9, small diﬀerences
were observed for GSH; these diﬀerences became increasingly promi-
nent with HCys and Cys. With Cys, a 10-fold diﬀerence in product yield
was observed between pH 7.4 and pH 9. When fresh human plasma was
added to NEM dissolved in buﬀer of diﬀerent pH, the changes in peak
areas were not as dramatic as with the mixture of reduced thiols in
aqueous solution. Yet, a few notable diﬀerences were observed: peak
areas decreased slightly with alkalinization for GSH and Cys and in-
creased rather more markedly for sulﬁde; a small increase compare to
physiological pH was also observed upon acidiﬁcation with Cys and
sulﬁde.
Taken together, this data suggests that adjustment of the reaction
pH from 7.4 to either more acidic or more alkaline conditions aﬀects
product yield and/or stability of the reaction product to a diﬀerent
extent with diﬀerent thiols, with the most dramatic variation observed
with Cys. If the calibration curves of the authentic standards at the
respective pH would be used, this would result in an overestimation by
a factor of 10 in the case of Cys. For sulﬁde, the same changes in pH
appear to result in increased sulﬁde amounts to become available for
reaction with NEM; whether this was a result of decomposition of
metastable per/polysulﬁdes or due to enhanced release of sulﬁde from
non-covalent binding sites remains unclear at this stage. All further
experiments were therefore carried out using NEM-containing stock
solutions kept at pH 7.4. Since the physiological pH of plasma, saliva
and cellular samples is almost always near this pH there is in fact no
need to add a stabilizing buﬀer for these compartments; however, the
pH of urine may vary from slightly acidic to alkaline, depending on
nutritional habits and metabolic status; thus, checking pH after addition
of NEM-containing buﬀer would seem to be advisable.
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3.5. Versatility for assesement of other thiols and sulfur metabolites
Having demonstrated that in principle our platform technology is
robust and allows sensitive, speciﬁc and simultaneous measurement of
multiple thiols, disulﬁdes and sulﬁde in plasma our next eﬀorts fo-
cussed on demonstrating its versatility. To this end, we tested how
cumbersome it would be to include an additional analyte into the ex-
isting method. Herein we show examples for three very diﬀerent
compounds: methanethiol (methyl mercaptan, CH3SH), N-acet-
ylcysteine (NAC), and coenzyme A (CoA). Establishing speciﬁc MRMs,
optimizing cone/collision energies and subsequently testing where the
compound elutes on the column takes approximately one day per
analyte using UPLC-MS/MS. NAC and CoA did not diﬀer much from
other thiols in terms of fragmentation properties. CH3SH was found to
be extremely sensitive to in-source fragmentation, requiring a very low
cone voltage for detection; it was also very well retained on the column,
eluting between the other thiols and sulﬁde (see Fig. 1C). NAC fell
within the same time window where other aminothiols elute, whereas
CoA showed an unusually strong interaction with the mixed mode
column. This resulted in extreme peak tailing, preventing inclusion of
CoA in the current method. Ongoing eﬀorts focus on developing a short
method for discrete measurement of this particular analyte using a C18
column. Thus, in principle, many new analytes can be incorporated into
the method within one day, although some compounds (here ex-
empliﬁed by CoA) may require additional development eﬀort and/or
alternative chromatography/elution conditions.
3.6. Optimization of sample preparation procedures for plasma: protein
removal and anticoagulant
To allow this method to be used in translational studies [3], we
focussed on the optimization of analysis of thiols and sulﬁde primarly in
biological matrices. Since blood is in contact with all tissues, it is likely
to represent not only a convenient biomarker matrix but also to play a
central role in systemic thiol and sulﬁde metabolism. A further ad-
vantage is that blood is relatively easily accessible. Therefore, in the
Fig. 2. Eﬀects of pH on the measurement of ami-
nothiols and sulﬁde using NEM. The eﬀect of pH was
investigated in a simple aqueous buﬀer (A) and in plasma.
(B). (A) Standard curves were prepared at four diﬀerent
pH values: 6, 7.4 (physiological), 8 and 9, using NEM in
ammonium phosphate buﬀer of the appropriate pH; the
insets represent the percentual changes of peak area/in-
ternal standard peak area as compared to the same values
obtained at pH 7.4 (black bars) for a 1 µM standard con-
centration. The largest impact of pH is seen for Cys with a
tenfold decrease in peak areas from pH 6 to pH 9, whereas
sulﬁde shows the least diﬀerence between the diﬀerent
pHs. Data are from 2 independent measurements. For GSH
and sulﬁde the diﬀerence between groups was not sig-
niﬁcant. 1-way ANOVA p < 0.01; Dunnet's v. pH 7.4
(black bar) * p < 0.05. (B) NEM in ammonium phosphate
buﬀer at each pH was added to fresh plasma samples. The
percentual changes of peak area/internal standard area is
presented relative to those at pH 7.4 (black bars), which
was considered as a control group. Contrary to the ana-
lyses carried out in buﬀer (shown in panel A), the largest
diﬀerences in measured peak areas were seen with sulﬁde,
with large increases above pH 7.4 as well as a slight in-
crease at pH 6. Data are from 6 independent samples. For
GSH, and HCys the diﬀerences among the groups were not
signiﬁcant. 1-way-ANOVA p < 0.001; Dunnet's v. pH 7.4
(black bar) * p < 0.05.
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present study we focused on optimizing sample preparation for blood
(although these procedures can be easily adapted to tissues and cells).
To avoid changes in thiol speciation (in particular sulﬁde) while
minimizing interference with chromatographic separation and analyte
detection, we opted to remove proteins by simple ultraﬁltration over a
10 kDa membrane. The advantages of this approach to sample clean-up
over protein precipitation methods include the avoidance of analyte
dilution, pH changes and addition of organic solvents, which may in-
terfere with the separation (please see Discussion for further com-
ments).
The choice of anticoagulant used to collect blood may have a sig-
niﬁcant impact on the concentrations of thiols/disulﬁdes and sulﬁde
measured, and previous work on glutathione emphasized the im-
portance of metal chelators to minimize artiﬁcial oxidation [44]. Our
ﬁrst eﬀorts to identify optimal conditions for combined thiol/sulﬁde
analysis in whole blood therefore focussed on the choice of antic-
oagulant (Fig. 3A). For reasons of practicality we limited our compar-
ison to using commercial vacutainer tubes. In all cases, NEM was added
immediately after ﬁlling and before centrifugation at 800×g for 10min
(the standard protocol used in many of our earlier studies). A ﬁnal
sample concentration of 10mM NEM was chosen in all the pilot work.
This had been successfully used by our group and others in the context
of NO related research to prevent changes in concentrations of nitrite,
nitrate and nitroso species in blood and tissues [45].
Blood was collected from three diﬀerent individuals into EDTA,
heparin, citrate or serum vacutainers and tested in direct comparison
(Fig. 3A). Citrated samples had a greatly reduced sulﬁde concentration
compared to other anticoagulants, likely due to the acidic nature of this
anticoagulant perhaps favoring volatilization of sulﬁde. Blood collected
in heparin tubes showed slightly higher levels of GSH and sulﬁde
compared to EDTA, but lower levels of Cys and CysGly. Serum tubes
were unsatisfactory for measurement of physiological levels of thiols
and sulﬁde as they showed greatly reduced concentrations of the ma-
jority of thiols measured (except GluCys) and sulﬁde. Whether this was
due to excessive protein thiolation as a result of the coagulation process
remains speculative at this juncture and was not further investigated. In
any case, these results seem clearly to rule out serum or citrate tubes for
thiol redox measurements. Since the concentrations of most analytes
measured were rather similar using either EDTA or heparin antic-
oagulated blood and the former may have an advantage inasmuch as it
minimizes thiol oxidation by metal chelation (obviating the need to add
another chelating agent) all further validation experiments were carried
out using EDTA as anticoagulant.
3.7. Sample stabilization with NEM
All thiols are susceptible to oxidation when exposed to ambient air,
and sulﬁde is in addition volatile; it would thus seem advisable to add
alkylating agents such as NEM as soon as possible to a biological sample
in order to avoid artiﬁcial shifts in the ratio of reduced to oxidized
thiols. For blood, we reasoned that it would be advantageous to add
NEM immediately after collection. As expected, delaying the addition of
NEM to whole blood resulted in lower levels of GSH being detected in
plasma (Fig. 3B). In contrast, sulﬁde showed an apparent increase in
concentration the longer the blood was left without derivatization. Ir-
respective of speciﬁc mechanisms involved it would seem advisable to
Fig. 3. Optimization of sample preparation procedure:
anticoagulation, and stabilization with NEM. For all
experiments depicted, NEM (or other thiol alkylating
agent) was added directly to whole blood (panels A-D)
after which the sample was centrifuged at 800×g for
10min at room temperature. In panel E NEM was added to
plasma directly after separation from blood cells by cen-
trifugation of whole blood. (A) The choice of antic-
oagulant aﬀects the concentrations of thiol measured;
because of its metal chelating properties EDTA is the most
suitable anticoagulant for assessment of the thiol redox
metabolome. 2-way ANOVA p < 0.0019, Dunnet's vs.
EDTA * p < 0.01 (B) Delay in addition of NEM to whole
blood leads to progressive decreases in GSH and CysGly
concentrations as compared to time =0. (C) The apparent
concentrations of GSH and sulﬁde increase with increasing
concentrations of NEM added to whole blood, as compared
to whole blood treated with 1mM NEM as a control
(centrifugation 800×g x 10min). (D) The concentration
of sulﬁde detected increases with increasing concentra-
tions of alkylating agents added to whole blood. (E) The
NEM concentration-dependent increases of GSH levels (as
compared to samples treated with 1mM NEM) were not
observed when NEM was added to plasma (although also
absolute GSH concentrations were considerably lower),
suggesting that these increases were largely due to leakage
of GSH from blood cells; however, apparent plasma sulﬁde
concentrations still increased with increasing NEM con-
centrations, suggesting removal of sulﬁde from bound
forms in plasma at elevated concentrations of the alky-
lating agent. For all panels data were obtained by analysis
of two independent biological samples taken form dif-
ferent human individuals (mean± SD); measurements
were carried out at least in duplicate.
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add the alkylating agent as soon as feasible to the biological sample of
interest.
Our next eﬀorts revolved around ﬁnding the optimal concentration
of NEM to achieve complete alkylation (Fig. 3C). The most abundant
thiol in human plasma is the single free sulfhydryl group of Cys-34 of
serum albumin [46], which is not analysed in this method but will still
react with (and thus consume) NEM. It has a plasma concentration in
the order of 0.3–0.4mM in healthy human individuals; to some extent,
NEM can also react with amine residues consuming additional
equivalents. Thus, to ensure that all of the low-molecular weight thiols
and sulﬁde are fully derivatized a range of NEM concentrations
(1–20mM ﬁnal concentrations) were tested. There was no signiﬁcant
change in concentration between 1mM and 5mM NEM for the majority
of analytes. However, the concentration of NEM used for derivatisation
of whole blood had a dramatic eﬀect on the apparent plasma levels of
GSH and sulﬁde recorded (Fig. 3C). Higher NEM concentrations sig-
niﬁcantly increased the levels of GSH and sulﬁde measured, while those
of other thiols were either not aﬀected or their concentrations were
slightly reduced. Sulﬁde levels showed the largest variation with dif-
ferent NEM concentrations, tripling between 1mM and 10mM NEM
and plateauing between 10mM and 20mM (Fig. 3C).
A striking observation was that, at the two highest concentrations of
NEM tested (10 and 20mM), measured plasma GSH concentration was
considerably higher than the range typically reported in the literature
[44]. By contrast, GSH and sulﬁde concentrations increased to a much
lesser extent when NEM was added to plasma after its separation from
RBCs (and other blood cells) by centrifugation (compare Fig. 3E and C).
This data suggests that the observed elevated plasma concentrations of
these two analytes, when higher NEM concentrations were added to
whole blood, were an artefact resulting from leakage and/or transport
of material from blood cells. This phenomenon was not speciﬁc to this
particular thiol alkylating agent since even higher levels of sulﬁde were
found when mBB instead of NEM was used as thiol alkylating agent and
added to whole blood under otherwise identical conditions. A direct
comparison of mBB, NEM and IAM (Fig. 3D) revealed that the latter
resulted in the lowest sulﬁde levels detected, demonstrating that the
nature of the alkylating agent applied can have a marked inﬂuence on
the levels of sulﬁde detected.
As centrifugation time itself contributes to the delay between col-
lection of blood and prevention of thiol oxidation by addition of NEM
and consequent loss of GSH (as observed in Fig. 3B) and other thiols the
centrifugation protocol was also optimized for centrifugation speed
(800–3000×g), centrifugation time (1–10min) and hemolysis of RBCs
(Fig. 4A,B). The latter is of critical importance due to the very high
concentration of GSH and sulﬁde within RBCs, such that small numbers
of ruptured cells can lead to dramatic increases in the apparent plasma
concentration of these analytes. None of the centrifugation protocols
tested induced hemolysis of RBCs as assesed by UV–vis spectro-
photometry of the plasma obtained after centrifugation, a simple pro-
cedure that can detect concentrations of free hemoglobin as low as
10 nM (a low-grade hemolysis corresponds to absorbance values of>
0.2 [39]). Nevertheless, a consistent ﬁnding was that the longer/low-
speed centrifugation (800×g, 10min) resulted in considerable leakage
of GSH from the cells (Fig. 4A – GSH, compare pink vs. blue bar).
Therefore, the optimal protocol chosen to preserve the natural
speciation of thiols and sulﬁde in blood was to add NEM to a ﬁnal
concentration of 10mM as quickly as possible upon collection of blood,
combined with a short/rapid centrifugation procedure (1min at
3000×g).
3.8. Sample storage and stability
For the most part, samples will have to be collected over longer
periods of time (and in case of multicenter studies even at diﬀerent
locations) requiring storage in the frozen state before analysis. We
therefore felt it was important to ensure that signal intensities of key
analytes did not suﬀer a dramatic loss upon freeze/thaw. As shown in
Fig. 4C, instead of any signiﬁcant decrease, some concentrations no-
tably increased after freeze/thawing, especially CysGly whereas others
such as sulﬁde did not change at all. The only exception was NAC,
which dropped by 30–50% after a single freeze/thaw compared to
immediate analysis. However, another obvious ﬁnding from these stu-
dies was that the extent of concentration changes observed varied
dramatically from individual to individual and between analytes, ran-
ging from a few percent to> 3-fold. Further stability tests with NEM-
treated samples showed no signiﬁcant changes in the levels of the
analytes when kept for extended time in the refrigerated autosampler
compartment or subjected to an additional freeze/thaw (Fig. 4D).
Therefore, human plasma samples stabilized with NEM can be frozen
without apparent loss in concentration of analytes; however, absolute
concentrations measured diﬀer from those apparent on immediate
sample analysis.
3.9. Accuracy for measurement of glutathione redox status and comparison
of analytical results
We sought to demonstrate the accuracy of our platform technique
by comparing the results obtained by an independent laboratory.
Instead of ultraﬁltration, this laboratory used a protein removal tech-
nique accepted and optimized for GSH/GSSG mesurements, i.e. by
precipitation with sulfosalicylic acid (SSA), along with a diﬀerent
chromatographic method (regular C18 instead of mixed mode material)
and mass spectrometry principle (ToF high resolution instead of triple
quadrupole; see Methods for details). Two other thiols (Cys, HCys) and
one disulﬁde (HCysSS) were also included in the comparison in addi-
tion to GSH/GSSG. The concentrations of these analytes were compared
between both methods in plasma from 10 healthy human volunteers
(Fig. 5). On comparison of Method A (ultraﬁltration and triple quad-
rupole) with Method B (SSA deproteinisation and QToF) we found that
deproteinization of samples with SSA leads to a statistically signiﬁcant
underestimation of GSH and GSSG, while Cys, HCys, HCySS yielded
consistently higher concentrations (Fig. 5A). These diﬀerences are
evident on Bland-Altman comparison of the methods (Fig. 5B).
3.10. Assessment of total and bound thiols by treatment with DTT
Total amounts of a speciﬁc thiol in a biological sample can be de-
termined by reduction of all disulﬁdes by DTT before NEM addition and
analysis, while the corresponding free thiol is assesed in DTT untreated
samples. The bound thiol levels are obtained by calculating the diﬀer-
ence of total thiols-free thiols. First, to ensure complete reduction of all
disulﬁdes (including sulﬁde) we determined the minimally eﬀective
concentration of DTT and the incubation time required to achieve the
highest ﬁnal concentration of LMW thiols and sulﬁde in the reaction
solution. Complete reduction was achieved by treatment of plasma with
50mM DTT for 10min at RT (sample workﬂow is shown in Fig. 6A).
Similar results were obtained by analyzing other bioﬂuids, including
saliva and urine, whereas human blood cells required 100mM DTT and
30min incubation for complete reduction (see below).
There were no signiﬁcant diﬀerences in the ﬁnal concentration of
thiols in plasma samples reacted with NEM before reduction compared
with samples reduced with excess DTT and then reacted with NEM.
As a proof-of-concept study, we determined the steady-state con-
centrations of free reduced and oxidized thiols as well as the total thiol
content in plasma of 10 healthy human volunteers (Table 2). The
concentrations listed correspond broadly to values previously reported
in the literature [46]. However, the distribution of circulating con-
centrations among healthy human volunteers highlights a number of
aspects that are usually less obvious by looking at averages. First, there
are considerable diﬀerences in concentration of free thiols between
individuals, varying from 2 to 3 fold in some cases to as much as 10-fold
for other analytes. Second, the ratios of reduced over oxidized thiols
T.R. Sutton et al. Redox Biology 16 (2018) 359–380
370
varies markedly between glutathione, cysteine and homocysteine.
Third, amounts of bound thiols are generally higher than circulating
concentrations of free reduced thiols; this is particularly striking for
GluCys and sulﬁde for example, where bound sulﬁde exceeds free sul-
ﬁde by a factor of 100. Persulﬁde and methanethiol were not detected
in any plasma sample. However, solutions of NEM-derivatized stan-
dards of persulﬁde (formally, the disulﬁde of H2S in its anionic form)
were found not to be stable over time, representing a methodological
limitation that is not easily overcome without switching to another
alkylating agent.
Overall, these data show that our method can also be applied for
high-throughput determination of free and protein-bound thiols in
human plasma.
3.11. Acid-labile sulfur and redox measurements in blood cells and other
bioﬂuids
In addition to the possibility of measuring free thiols and subjecting
aliquots of the same biological specimen to additional reduction with
excess DTT (before or even after addition of NEM) to liberate bound
thiols, another sample aliquot can be pretreated with acid, neutralized
and then reacted with NEM to measure acid-labile sulfur (and other
thiol-containing species that may be released upon this treatment; see
Fig. 6A for workﬂow). Fig. 6B-D shows exemplary results using this
sample workﬂow for blood cells and two other bioﬂuids, urine and
saliva. It is immediately apparent from this comparison that not only
absolute concentrations diﬀer dramatically between diﬀerent biospe-
cimen, but also the distribution of thiols (i.e. the proportion of free
versus bound, and acid-labile). Similar to plasma (Table 2), bound cy-
steine exceeded free levels by more than an order of magnitude in urine
and saliva; however, bound glutathione was only found in saliva, not
urine or blood cells. Somewhat lower levels of cysteinylation but es-
sentially no glutathionylation were found in blood cells. Signiﬁcant
amounts of acid-labile sulfur are present in saliva, urine and blood cells.
Unexpectedly, not only sulﬁde concentrations were increased following
sample acidiﬁcation, but some thiols also showed clearly higher levels
compared to untreated controls. This was particularly evident for me-
thanethiol, concentrations of which increased approximately 50-fold
upon acidiﬁcation in urine; methanethiol concentrations in blood cells
and saliva remained below the quantiﬁable limit. It is important to
point out that under acidic conditions the NEM-sulﬁde adduct is likely
to originate not only from reaction with free HS- but also with both
protein-bound and LMW polysulﬁdes due to the susceptibility of these
compounds to acid hydrolysis.
In summary, an additional straightforward sample pre-treatment
allows further expansion of the measurement opportunities to include
acid-labile sulfur species in biological samples. While there seems to be
some overlap between DTT-reducible and acid-labile material distinct
diﬀerences remain, suggesting diﬀerent chemical characteristics of the
biological material susceptible to reduction and acid-treatment.
4. Discussion
We here outline a novel speciﬁc, highly sensitive and robust mass
spectrometry-based approach for the measurement of the thiol redox
metabolome capable of quantifying total and free thiols, and their cor-
responding disulﬁdes as well and sulﬁde in complex biological matrices
such as blood, saliva and urine. Speciﬁcally, we describe our validation
work focusing on i) the development of the analytical procedure, i.e.
suitable detection and separation conditions, quantiﬁcation strategy
Fig. 4. Optimization of sample preparation procedure: eﬀects of centrifugation speed and duration, eﬀects of freeze/thawing and sample stability. (A,B)
NEM addition to whole blood (shown in A) increases stability of thiols in comparison to NEM addition to plasma (shown in B), as demonstrated by comparing overall
absolute concentrations of the same thiols in A vs. B. However, when low speed/long duration centrifugation (800×g, 10min) was chosen to separate plasma form
blood cells this procedure artiﬁcially increases plasma GSH concentrations (shown in A, pink bar vs. blue bar), probably due to leakage of NEM-adducts form cellular
blood components (RBCs); see main text. (C) Freezing of NEM stabilized plasma leads to an increase in GSH, Cys and CysGly concentrations compared to their levels
in fresh samples; concentrations of GSH dramatically decreased, and GSSG increased when samples were frozen without stabilization by NEM (n=3; 2-way RM
ANOVA p < 0.001; Dunnet's vs. fresh plasma p < 0.01). (D) In samples stabilized with NEM freeze/thawing or maintenance of samples in thermostatted auto-
sampler at 5 °C did not aﬀect concentrations of the redox thiol metabolome (n=3, diﬀerences among groups are not signiﬁcant). For all panels 2 or 3 independent
biological samples from diﬀerent individuals were analyzed; measurements were carried out in triplicates. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article).
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(external and internal standards, linearity, and versatility of the
method); ii) optimization of sample preparation, using blood as starting
material (choice of anticoagulant, sample stabilization, centrifugation
and storage); iii) versatility of the method with examples of how further
compounds of interest can be included for a more comprehensive
coverage of the thiol redox metabolome in the future; iv) determination
of the accuracy for detection of glutathione redox status as compared to
an optimized, well established method; v) analysis of the thiol meta-
bolome (including total and free thiols and their corresponding dis-
ulﬁdes, as well as hydrogen sulﬁde) in plasma samples of 10 healthy
human volunteers, as well as in blood cells, urine and saliva. Taken
together, this data indicates that the approach can be used to char-
acterize the redox metabolome in patient cohorts and animal models of
disease. It can therefore be applied in clinical and translational studies
in search for novel prognostic and diagnostic strategies for patient
stratiﬁcation; moreover, it may assist in identifying novel
interventional approaches for the treatment of redox diseases [3].
4.1. Is there a need for yet another method to determine thiol redox status?
There is no shortage of analytical methods for the determination of
biological thiols (for recent reviews see [47,48]), and many more assays
appeared in just the last couple of years. Several of those more recent
additions to our analytical armamentarium use a combination of some
form of chromatographic separation (HPLC, UPLC or capillary elec-
trophoresis) and mass-spectrometry for detection. In most (albeit not
all) cases, the latter oﬀers better selectivity and higher sensitivity
compared to earlier spectrophotometric, ﬂuorimetric, chemilumines-
cence or electrochemical detection approaches. While there are plenty
of choices for the quantiﬁcation of reduced thiols, much fewer techni-
ques exist for the measurement of oxidized thiols, in particular at their
low natural abundance; however, this is of utmost importance for an
Fig. 5. Determination of the accuracy of the method (Method A) by comparison with an independent method optimized for GSH/GSSG detection (Method
B) in plasma samples from 10 healthy human volunteers. In Method A detection of the thiol redox metabolome was carried out after ultraﬁltration, separation on
the Aqua UPLC column and detection by triple-quadrupole mass spectrometry. In Method B, thiols and disulﬁdes were measured following deproteinization with
sulfosalicylic acid, separation on a C18-UPLC column, and detection by Q-ToF mass spectrometry. (A) Concentrations of GSH are grossly underestimated by Method B,
while Cys, HCys and HCysSS are overestimated by Method B compared to Method A (n= 10; 2-way RM ANOVA Method A vs. B p < 0.0001; Sidak's multiple
comparison test p < 0.01; # T-Test-p < 0.01). (B) Bland-Altman plots of the absolute diﬀerences in GSH and GSSG concentrations as assessed by Method A -
Method B in relation to the mean values of the analytes. (C) Eﬀects of freeze/thawing were absent when Method B (with SSA deproteinization) was used (n=3).
Both methods revealed very similar values when the same sample clearing/deproteinization procedures were applied. For all panels 3–10 independent biological
samples were analysed; measurements were carried out in triplicates.
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accurate assessment of thiol redox equilibria. Given the signiﬁcance of
glutathione as cellular antioxidant the majority of analytical develop-
ments revolved around GSH/GSSG. Since the pioneering analytical
work of Reed et al. [15] most investigators are aware of the need to
prevent thiol oxidation in order to avoid an artiﬁcial elevation of dis-
ulﬁde levels. However, not only GSH/GSSG but also the extracellular
cysteine/cystine ratio is an important read-out of the whole body redox
poise (and apparently uncoupled from the glutathione redox) [1], and
the ratio of cystine and glutathione has recently been proposed as a new
biomarker for oxidative stress in the cardiovascular disease setting
[17]. Yet, an even simpler measurement of total serum free thiols by
means of Ellman's reagent has been shown to predict mortality in pa-
tient cohorts [23,24]. How the latter relates to glutathione and cysteine
redox state is currently unknown. While the complexity of changes in
extracellular thiol levels has been recognised and the dynamic inter-
action between free reduced and oxidized as well as protein-bound thiols
been deﬁned as “plasma redox thiol status” more than two decades ago
[49] the main factors and regulatory element that deﬁne these inter-
actions in whole blood remain ill deﬁned. This uncertainty is accom-
panied by new developments that appear to highlight the involvement
of sulﬁde and associated metabolites such as inorganic and organic
persulﬁdes and polysulﬁdes [5,6,26]. This interaction gives rise to
oxidized thiols in which the sulfur of the SH group of Cys, GSH or
sulﬁde (and likely other thiols) is bound to one or more sulfur atoms;
the properties of the resulting thiol derivatives diﬀer fundamentally,
both chemically and biologically, from the originating thiols [50,51].
Fig. 6. Assessement of free, total and acid-labile thiols in human blood cells, urine and saliva. (A) Workﬂow for determination of free (1), total (2) and acid-
labile thiols (3) in biological samples such as blood plasma (Table 2), blood cells (panel B) and other bioﬂuids (panels C,D). (B-D) For the determination of free, total
and acid-labile thiols in blood cells (depicted in B), urine (shown in C) and saliva (shown in D), samples were divided into 3 aliquots; one aliquot was used for
determination of free thiols, one for total thiols following DTT reduction, and one for acid-labile thiols after addition of hydrochloric acid (HCl) and subsequent
neutralization by sodium hydroxide (NaOH). All measurements were carried out in triplicate. Data in B are means from individually analysed cell pellets of the same
10 volunteers of whom circulating plasma thiol concentrations were analysed for inclusion in Table 2; data in panels C and D were from pooled saliva and urine
samples of 5 healthy volunteers.
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Moreover, even seemingly well characterized compounds such as
glutathione seem to have additional actions beyond those of their
classical antioxidant function, which would seem to warrant further
exploration [52]. Yet, many pitfalls surrounding its analysis in cells and
bioﬂuids (some of which have been known for decades) often appear to
have been neglected and remain to be better characterized to avoid the
enormous variations in GSH/GSSH ratios reported in the literature
[53]. Even sophisticated, validated and robust methods for the si-
multaneous determination of glutathione and cysteine redox state [54]
would seem to leave room for improvement inasmuch as pre-analytical
sample handling is somewhat cumbersome and time-consuming, in-
volving multiple steps, and total assay time is rather long by today's
standards. More importantly, however, the technique used in this par-
ticular case (which is based on the technique established by Reed et al.
[15]) is unsuitable for the analysis of thiols that do not also contain an
amino group such as sulﬁde or methanethiol. Hence, novel analytical
methods with improved sensitivity and speciﬁcity, a simpliﬁed work-
ﬂow and higher speed of analysis without compromising robustness and
versatility are required to allow future study of the complex interac-
tions between diﬀerent elements of the thiol redox metabolome in
larger numbers. Herein, we provide one example for how such an ap-
proach might be put into action.
4.2. Establishing an analytical platform for detection of the redox
metabolome
Here we describe the necessary steps needed to establish an analy-
tical platform for high-throughput characterisation of the thiol meta-
bolome in biological matrices. As soon as the analytical instrumentation
is available, the ﬁrst fundamental step to this end is to deﬁne the re-
levant target analytes as well as the internal standards for their quan-
tiﬁcation; from there on, one can proceed with optimization of detec-
tion and separation conditions as well as a critical assessment of
linearity, precision, LOD and reproducibility of the method. These steps
are clearly dependent on the type of instrumentation available, but in
part also on the diﬀerent chemistry of the analytes intended to be
covered. However, the main objective of the present method develop-
ment was not to identify ideal conditions for analysis, but rather to ﬁnd
conditions that are ﬁt-for-purpose for high-throughput redox proﬁling
of large numbers of samples under everyday conditions. To this end, we
found that it was not the instrumentation available but rather the
sample preparation that represented the most important factor which
deﬁnes the qualitative and quantitative results.
We chose human blood as suitable starting material for our devel-
opment. The reason for this choice was severalfold: not only is it a
readily accessible and relatively abundant starting material, but it also
represents a sort of systemic equilibration medium that is in contact
with all other compartments of the body [3]. The redox buﬀering ca-
pacity of the blood (and in particular of RBCs) is notoriously high, and
it appears to be kept constant by multiple enzymatic and non-enzymatic
mechanisms [3,55]. For the same reasons the determination of ‘redox
reserve’ (total thiols) and ‘redox status’ (ratio of reduced/oxidized thiols)
in blood may be relevant to understand the status of biological ﬁtness
and resilience of an individual (or animal) under study.
The ﬁrst critical steps during development were therefore to ﬁnd a
way to stabilize the sample, to separate cellular components from the
plasma without damaging RBCs (which contain millimolar concentra-
tions of GSH [55]), in a quick and straightforward way, compatible
with rapid and reproducible collection of clinical specimens in a critical
care setting, for example. We found that one of the easiest ways to
collect blood in this context was to choose commercial EDTA vacutai-
ners since this anticoagulant is also a metal chelator, which may help
avoiding secondary metal-dependent oxidative reactions (such as the
Fenton reaction). Reduced thiols in EDTA anticoagulated blood can
then be stabilized by treatment with an excess of alkylating agent,
added within the ﬁrst 1–2min after blood withdrawal. In the present
study we used NEM for this purpose, whilst others have used diﬀerent
alkylating agents such as IAM or mBB. We opted for NEM due to its
superior speed of reaction with SH groups at physiological pH (see
below). Regardless of the nature of alkylating agent employed in this
context, we observed that addition of these chemicals to whole blood
leads to an artifactual increase in GSH and sulﬁde concentrations in
plasma if centrifugation is carried out at low speed for too long. This
problem was circumvented by use of a high-speed/short-centrifugation
protocol for cell separation, indicating that this phenomenon was an
artefact possibly due to an alkylation-induced increase in RBC mem-
brane permeability. Indeed, NEM is well known to aﬀect RBC mem-
brane properties, inducing a loss of membrane asymmetry and exposure
of phophatidylserine as well as to modifying critical thiols in ion
channels and transporters, thereby aﬀecting ion exchange processes,
decreasing cell deformability and increasing membrane leakage [55].
Another important factor that requires careful consideration in
methodological developments is the choice of protein removal method.
Biological ﬂuids such as plasma are complex matrices, the constituents
of which can potentially cause interference with chromatographic se-
paration and analyte detection by e.g. lowering ionization eﬃciency or
ion suppression. In the present study, biological samples were cleared
before analysis, and the majority of proteins were removed by ultra-
ﬁltration over a 10 kDa cut-oﬀ membrane using centrifugal columns.
The classical methods described for determination of aminothiols,
speciﬁcally GSH, using either chromatographic techniques or enzy-
matic assay, also normally include a protein removal step. Many stan-
dard deproteinization procedures are based on addition of acids (tri-
chloroacetic acid, SSA) or metals like zinc sulfate/NaOH. Clearly, either
of these methods would cause drastic changes in pH, which may aﬀect
detection of sulfur species and sulﬁde [27]. In fact, sulfur species are
well known to be particularly labile under acidic conditions; on the
other hand, sulfur can be released from thiols under alkaline conditions
[27], leading to an artiﬁcial elevation of sulﬁde. In addition, zinc sul-
fate is known to trap free sulﬁde and form a water-insoluble ZnS pre-
cipitate. Alternative protein removal processes include addition of polar
organic solvents such as methanol, acetonitrile or acetone, or solid
phase extraction. We observed that using organic solvents for protein
precipitation decreases the recovery of GSSG; moreover, the high con-
centration of organic solvent in the sample sometimes interferes with
the chromatography (which often requires an almost complete aqueous
phase to start with). Therefore, in order to quantify aminothiols and
sulﬁde using an identical sample processing procedure, clearing sam-
ples by ultraﬁltration, which does neither change the pH nor add any
acid or solvent, to us appears to be best practice, at least for matrices
such as plasma.
A further important step was to determine the stability of the
samples after freeze/thaw. We found that except for NAC (levels of
which dropped by 30–50% after freeze/thaw compared to immediate
analysis) concentrations of all other thiols did not drop but rather in-
creased in concentrations after freeze/thaw. The reason for this beha-
vior is not immediately obvious, but clearly there is no problem with
the stability of the thiol-NEM adduct. We suspect that this observation
may be related to the stability of thiol derivatives that previously es-
caped detection (perhaps a metastable compound that decomposed
during the freeze/thaw process such as a persulﬁde and/or polysulﬁde).
However, levels of sulﬁde did not change under the same conditions,
suggesting that the product of decomposition of these per/polysulﬁdes
might be a higher oxidized form not captured by our assay.
Interestingly these eﬀects of freeze/thaw were not observed when
proteins were removed by addition of SSA. This suggests an alternative
explanation that is even more intriguing: conceivably, aminothiols may
exist not only in free and protein-bound form (whereby binding is via a
mixed disulﬁde and therefore DTT-reducible), but a fraction of them
also binds to proteins in a non-covalent fashion. When protein con-
formation is changed by precipitation with acid/organic solvents or as a
consequence of a freeze/thaw process this non-covalent association is
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perturbed, making more aminothiols available for trapping by the ex-
cess NEM present. This scenario might also explain the apparent dif-
ferences in absolute concentration of analytes (which were independent
of the detection method) when plasma was processed by ultraﬁltration
versus acid precipitation; moreover, it might oﬀer an explanation for
our observation that not only sulﬁde, but also the concentration of some
aminothiols increases upon acid treatment. The notion of non-covalent
protein binding of thiols is also consistent with the observed con-
centration-dependence of NEM in plasma - why should levels of certain
aminothiols (and sulﬁde) otherwise further increase with higher NEM
concentrations unless they are removed from an equilibrium? This
concentration-dependent phenomenon was particularly prominent with
sulﬁde (see Fig. 3E), and consistent with a recent report that H2S non-
covalently binds to albumin and hemoglobin [36]. These aspects of the
thiol redox metabolome would seem to warrant further investigation as
it might oﬀer yet another, hitherto unrecognized level of redox reg-
ulation by modulation of protein association.
4.3. Choice of alkylating agent - Why NEM?
Many diﬀerent thiol alkylating agents and strategies have been
developed over the years, and compounds used not only diﬀer in che-
mical structure and reactivity but also in the mechanism by which they
interact with thiols. Therefore, selection of the most appropriate com-
pound for thiol derivatization will be determined by the purpose of its
use [56,57], for example whether the goal includes either labelling or
blockage of reactive thiol groups in proteins, thiol quantiﬁcation in
biological samples, or the prevention of autoxidation.
NEM is well known for its usefulness in characterizing sulfur me-
tabolism due to its propensity to rapidly react with SH groups [58]. As a
result of its reaction with protein thiols and SH-containing cofactors it
can inhibit intermediary metabolism, block vesicular transport, activate
speciﬁc ion channels and interfere with cell replication, for example.
Half a century ago, it was also employed for the spectrophotometric
measurement of SH groups [59]. NEM and related maleimides have
since been widely used for the analysis of thiols, including GSH [60,61],
for the prevention of GSH autoxidation [61] to stabilize human blood
for later quantiﬁcation of thiols/disulﬁdes [62]; even in a similar
workﬂow for sulfur pathway analysis using a diﬀerent chromatographic
separation [63]. It has also been known for some time to react with
sulﬁde [38,43]. However, to the best of our knowledge this property
has not been used for development of a combined method for thiol and
sulﬁde detection using mass spectrometry.
Of note, the compound's speciﬁcity for thiols is not absolute. At high
concentrations, NEM can also react with amino groups of peptides/
proteins and aminothiols [64]. In fact, its speciﬁcity for SH groups
strongly depends on reaction conditions; the side-reaction with amines
does not pose a major problem as long as the pH of the reaction solution
is kept near neutral. However, reagent concentrations in excess of those
found optimal for the majority of analytes in a speciﬁc biological matrix
(determined to be 10mM NEM for plasma in the present study) may
lead to lower apparent concentrations of select analytes. Cys is a case in
point and has been shown to undergo intramolecular transamidation to
form a cyclic reaction product; this reaction can run to completion
under alkaline conditions [64], and this may well account for the
progressive descrease in apparent Cys levels in Fig. 3C (when increasing
NEM concentrations were tested) as well as the drop in reaction yield
when pH was changed from 7.4 to 9 (Fig. 2B). Yet, apart from these
examples and in spite of its widespread use as a pharmacological and
analytical tool for decades, it is somewhat surprising that the reaction
mechanism of NEM with thiols has not been investigated in much more
detail (this could change in the near future as the underlying chemistry
also forms the basis for numerous applications in materials chemistry
including the surface modiﬁcation of porous polymeric monoliths used
in chromatography columns [65,66]).
In order to appreciate NEM's uniqueness among thiol-reactive
compounds and explain some of our experimental ﬁndings with dif-
ferent aminothiols and sulﬁde (as well as polysulﬁdes) it may be in-
formative to brieﬂy review key mechanistic aspects of the chemical
reaction. This is of importance since reaction conditions not only aﬀect
the stability of NEM and the ﬁnal reaction product (both of which are
subject to alkaline hydrolysis [43,67,68], but also speed and nature of
the reaction itself as well as its speciﬁcity for SH groups over reaction
with amines. The pH plays a central role not only for reagent and
product stability, but also because it aﬀects, along with the pka of the
SH group, the amount of thiolate available. It is a fortunate coincidence
for analytical chemistry that the reaction of NEM with thiols proceeds
optimally around the physiological pH, i.e. in the range of 7–7.5.
NEM and related maleimides are electron-deﬁcient compounds
(electrophiles) that participate in chemical reactions by accepting an
electron pair of a nucleophilic compound such as a thiol. As a maleic
acid derivative it also has an activated double bond with which thiols
can react. The pH-dependence of NEM's reaction with GSH and Cys
[43,69] indicated that only the thiolate (RS-) and not the undissociated
thiol (RSH) reacts with NEM. The mechanism involves a nucleophilic
addition of the thiolate (a strong nucleophile) onto the oleﬁnic (C˭C)
bond of the maleimide ring, forming an intermediate carbon-centered
anion; as a strong base this immediately abstracts a proton from the
conjugate acid (RSH) or from water, yielding the thioether (see Scheme
1). Reactions of a nucleophile with an α,β-unsaturated carbonyl (or
another electron-withdrawing group) are known as ‘Michael addition
reactions’ of which the thiol-NEM reaction is a special case. Since the
sulfur can add to either side of the double bond it gives rise to diﬀerent
diastereomeres (see Fig. 1B), sometimes complicating the chromato-
graphic separation of thiols [41] by leading to double peaks. Formation
of the maleimide-thiol adduct was long thought to be irreversible
(unless subjected to electrolysis). More recent studies, however, have
documented retro reactions to occur even under physiological condi-
tions, explaining e.g. the faster-than-expected cleavage of certain anti-
cancer immunoconjugates and PEGylated products in circulation [70].
For analytical purposes, this is not a concern as such reactions typically
proceed over many hours/days and require elevated temperatures.
The reaction of NEM with sulﬁde deserves special attention not only
because two molecules of NEM bind to either side of the sulﬁde-sulfur
(Fig. 1B and Table 1), but also because the same reaction can occur with
polysulﬁdes (as demonstrated here for hydrogen persulﬁde; see Section
3.10). The NEM adduct of S22- (Table 1) was found to be unstable and,
over time, decomposed to yield additional S-(NEM)2. The reason for the
instability of this thiol adduct is not known, but may be related to the
ease with which sulﬁde chains can break and/or how favorable e.g. the
NEM-S˙ radical is as a leaving group. Whatever the reason, the in-
stability of S2(NEM)2 is in line with recent ﬁndings by Akaike's group
demonstrating that NEM is unsuitable for the determination of cystei-
nepersulﬁde/polysulﬁde concentrations in biological tissues (Suppl
Fig. 2 in [71]). Extrapolating those results to hydropolysulﬁdes (Sx2-
where x can be 2–7) one may expect that part of the sulﬁde detected by
NEM in plasma does not originate from free HS- but be derived from
organic and inorganic per- and polysulﬁdes. Our comparison with mBB
Scheme 1. Mechanism of the reaction be-
tween N-ethylmaleimide and thiols (RSH)
in aqueous solution. R- alkyl chain with ad-
ditional functional groups (as in aminothiols),
hydrogen (as for sulﬁde) or sulfur chains of
various length (as in polysulﬁdes).
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(the current “gold-standard” for sulﬁde measurement) suggests that this
reagent may suﬀer from the same limitations. Thus, measured sulﬁde
concentrations with these reagents may represent the sum of free HS-
and per/polysulﬁdes, and this warrants further investigation. If in ad-
dition free sulﬁde is also in equilibrium with protein associated forms it
may be diﬃcult, if not impossible, to determine the concentration of
free sulﬁde in a given biological system – however, the sum of free and
non-covalently bound sulﬁde and polysulﬁde (or simply “NEM-sensitive
sulﬁde”) may still be a biological meaningful measure.
NEM has a number of advantages over other thiol alkylating com-
pounds. This includes foremost the speed of reaction with thiols, which
is considerably faster than that of mBB or IAA/IAM. This makes it
ideally suited for the prevention of autoxidation of thiols to their dis-
ulﬁdes during sample preparation. Another advantage is that as an
uncharged molecule, it easily penetrates cell membranes – a property it
shares with mBB and IAM. While this can be an advantage for the
analysis of tissue and intracellular biothiols, we here show that the
same property can also lead to an overestimation of true plasma levels
unless certain sample handling conditions are met. An advantage that is
particularly relevant for mass spectrometric detection is the fact that
reaction with NEM improves the ionization eﬃciency of thiols [72],
which explains the excellent sensitivities achieved using ESI-MS/MS,
for example.
4.4. Assessment of free and bound thiols in human plasma and other
bioﬂuids; workﬂow extension to include acid-labile sulﬁde
Not only can thiols be oxidized (in vivo and artiﬁcially during
sample handling) to form symmetric disulﬁdes (e.g. from GSH, GSSG and
from Cys, CysSS), they also engage in the formation of mixed disulﬁdes
leading to formation of both LMW and protein disulﬁdes. It was pro-
posed that these protein-bound asymmetric disulﬁdes may either re-
present a post-translational modiﬁcation or be involved in inter-organ
thiol transport [3]. It is important to note that formation of protein-
bound asymmetric disulﬁdes may mask detection of a particular thiol, if
only free thiol concentrations are assessed. Therefore, if determination
of the total amount of a speciﬁc thiol (like HCys) is required for diag-
nostic or prognostic purposes, total (bound+free) thiol concentrations
are determined following reduction of the covalent bond between the
protein thiols and the LMW thiol. Indeed, determination of total HCys
was demonstrated to be more predictive of certain pathophysiologies as
compared to free HCys [73]. For this purpose we subjected the biolo-
gical samples tested (plasma, blood cells, urine, and saliva) to reduction
by DTT. To ensure complete reduction of all bound thiols (incl sulﬁde)
we determined that the minimally eﬀective concentration of DTT and
incubation time required to achieve the highest maximal concentration
of LMW thiols and sulﬁde in the ﬁnal reaction solution was 50mM DTT
and 10min incubation at RT for all biological matrices tested except
blood cells. The latter matrix required 100mM DTT and 30min in-
cubation for complete reduction, emphasizing the importance to vali-
date each step of the analytical procedure for the biological matrix
intended to be investigated. For plasma analysis DTT was added to
NEM-stabilized plasma. However, no signiﬁcant diﬀerence in ﬁnal
concentrations of total thiols were found between samples that had
been reacted with NEM before reduction and those that were reduced
with excess DTT and then reacted with NEM; this demonstrates that, in
contrast to alkalinization which leads to hydrolysis and ring-opening of
the thioether [67], the thiol-maleimide adducts formed are stable under
acidic conditions.
Acid-labile sulfur is found in bacteria, mammalian and plant cells/
tissues, and various analytical methods are available for its quantiﬁ-
cation [74,75]. However, origin and biological role of this “pool of
sulﬁde” remains enigmatic. While its presence in cells and tissues has
been ascribed to metal-sulﬁde complexes such as iron-sulfur proteins
(e.g. aconitase involved in intermediary metabolism) and Fe-S clusters
in complexes of the mitochondrial respiratory chain, sources in
bioﬂuids are believed to be mainly organic or inorganic per- and
polysulﬁdes. Thus, the additional sulﬁde demonstrated here to be
captured as NEM-adduct following sample treatment with acid may
originate from a variety of sources including protein-bound and LMW
polysulﬁdes. Some but not all of the DTT-reducible thiols may be acid-
labile, although these two classes have been shown earlier to be che-
mically distinct [76].
4.5. Assessment of other thiols and sulfur metabolites: versatility, limitations
and outlook
Herein we show that this method may easily be adapted to measure
additional very diﬀerent compounds, including CH3SH, NAC and CoA.
CH3SH is a bacterial metabolic product that also arises as a result of
methylation of sulﬁde and methionine transamination in mammalian
cells [77–79], and a human methanethiol oxidase has been identiﬁed,
which metabolizes CH3SH to H2O2, formaldehyde and sulﬁde [80]. We
found CH3SH to be very well retained on the column, eluting between
the other thiols and sulﬁde but to be extremely sensitive to in-source
fragmentation. NAC assumes particular importance in bioavailability
monitoring following its oral application as antioxidant or as a muco-
lytic drug. Determination of CoA in plasma and other body ﬂuids may
also assume a particular importance for redox-related studies, because
it is a quantitatively important thiol involved in intermediary meta-
bolism that engages in S-thiolation reactions in much the same manner
as glutathione [81,82]. We had some technical diﬃculties with this
particular analyte as the NEM adduct of CoA was retained too strongly
by the column due to multiple mechanisms of retention, making it
impossible to measure circulating plasma concentrations of this im-
portant intermediary metabolite along with other thiols and sulﬁde in
the same run. Nevertheless, we are conﬁdent this can be resolved using
either a diﬀerent separation column or modiﬁed chromatographic
conditions, and this is a focus of our ongoing eﬀorts. This method may
be also implemented to assess further key intermediates of the me-
thionine recycling and transsulfuration pathway by the addition of
further related compounds such as methionine, S-adenosyl-methionine,
S-adenosyl-homocysteine and cystathionine to the existing method,
eventually enabling to capture the sulfur metabolome in its entirety.
It is important to note that sulﬁde levels assessed here by NEM
derivatisation are higher compared to methods using other protocols
employing mBB [33,35]. In our hands, absolute “free” sulﬁde levels are
strictly dependent on the alkylating agent used, and may depend on the
chemistry of the reaction of the alkylating agent; very diﬀerent con-
centrations in apparent sulﬁde concentrations were found with aliquots
of the same sample using NEM, IAM or mBB. The reason for these
diﬀerences warrants further elucidation. Of note, other reports de-
monstrated that e.g. dBB can extract sulfur from other sources [83], and
that NEM reacts diﬀerently with polysulﬁdes as compared to IAM or
IAA [71].
4.6. Strengths and limitations
The platform technology we present here for the measurement of
reduced and oxidized thiols in combination with sulﬁde related meta-
bolites appears to be robust, sensitive and versatile. Its strengths in-
clude the possibility to measure the thiol redox metabolome including
total and free thiols and their corresponding disulﬁdes as well as sulﬁde
in complex biological matrices; the technique can be easily combined
with other compatible analytical procedures for detection of NO me-
tabolites and nitrosospecies, as established by us before [45,84], using
NEM for stabilization of thiols. This may provide a deeper under-
standing on the systemic thiol redox state within the RSI. We made an
eﬀort to simplify workﬂows for sample preparation and storage, rea-
lizing there will be a need to translate critical steps into easy-to-follow
standard operating procedures, in particular when measurements have
to be carried out in large numbers, human studies are run in a multi-
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center fashion and/or biobanked samples are used. Lack of reproduci-
bility and robustness or a very particular sample handling requiring
specialist training could easily make a particular method wrongly ap-
pear unsuitable for use in clinical studies, or worse perhaps, lead clin-
icians towards incorrect treatment decisions.
Despite careful optimization, some technical limitations remain. In
the current conﬁguration these relate to the relatively poor retention of
CysSS on the column, which together with an unknown and variable
interference from plasma constituents causes ionization quenching,
leading to an underestimation of the true concentration of this disulﬁde
in plasma. This appears less of a problem (or no problem at all) in other
biological matrices such as RBCs and murine tissues and may be par-
tially overcome by using the standard addition method to determine
absolute concentrations. Moreover, as discussed above, sulﬁde levels
appear higher than with other methods, calling for a systematic com-
parison of the leading methods described for sulﬁde assessement
[27,31].
Furthermore, there may be a need for additional methods to cover
the per- and polysulﬁdes as important compounds bridging aminothiol
and sulﬁde chemistry. As discussed above, a major limitation of the
application of NEM is the fact that it cannot be used for detection of per-
and polysulﬁdes, for which the use of β-(4-hydroxyphenyl)ethyl io-
doacetamide was carefully optimized and successfully applied in cells
and tissues by the group of Akaike and co-workers [71]. The inclusion
of these compounds for assessment of the redox metabolome would
seem to be a sensible complementary approach to the analytical plat-
form we here introduced.
4.7. Summary and perspective: main lessons learned from this development
We have outlined a novel speciﬁc, highly sensitive and robust mass
spectrometry-based approach for quantiﬁcation of the thiol redox me-
tabolome. During the development of this analytical approach, we
realized that the majority of variability that can be appreciated in the
literature assessing aminothiols (and even more in the literature de-
scribing the methods to measure sulﬁde) originates from sample pro-
cessing procedures rather than the actual analytical method itself. The
use of authentic standards and stable isotope labelled internal standards
(which are readily available for most aminothiols and sulﬁde) allow
optimization of these methods with limited eﬀort. The choice of ana-
lytes to be measured and the availability of the standards should drive
the optimization procedures. However, procedures of sample stabili-
zation, for cellular separation and/or isolation (including centrifugation
and eventually tissue digestion with detergents), conservation and
freeze/thaw cycles all profoundly aﬀect the results produced and
therefore also require careful optimization for each biological matrix of
interest. Although the analytical approach with NEM presented here is
not suited to cover the per- and polysulﬁde interface, the principles
described here may be applied to ﬁnd an approach allowing detection
of an even broader spectrum of metabolites belonging to the thiol redox
metabolome. In conclusion, these principles can be applied to assess the
thiol redox metabolome in patient cohorts and animal models of dis-
ease, thus allowing the identiﬁcation of the regulatory nodes of redox
signaling, while enabling diagnosis, risk assesment, patient stratiﬁca-
tion and prognosis of redox diseases.
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